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Background: Inter-professional collaborative care (ICC) for cancer leads to multiple system, organizational,
professional, and patient benefits, but is limited by numerous challenges. Empirical research on interventions that
promote or enable ICC is sparse so guidance on how to achieve ICC is lacking. Research shows that ICC for
diagnosis could be improved. Diagnostic assessment programs (DAPs) appear to be a promising model for
enabling ICC. The purpose of this study was to explore how DAP structure and function enable ICC, and whether
that may be associated with organizational and clinical outcomes.
Methods: A case study approach will be used to explore ICC among eight DAPs that vary by type of cancer (lung,
breast), academic status, and geographic region. To describe DAP function and outcomes, and gather information
that will enable costing, recommendations expressed in DAP standards and clinical guidelines will be assessed
through retrospective observational study. Data will be acquired from databases maintained by participating DAPs
and the provincial cancer agency, and confirmed by and supplemented with review of medical records. We will
conduct a pilot study to explore the feasibility of estimating the incremental cost-effectiveness ratio using person-level
data from medical records and other sources. Interviews will be conducted with health professionals, staff, and referring
physicians from each DAP to learn about barriers and facilitators of ICC. Qualitative methods based on a grounded
approach will be used to guide sampling, data collection and analysis.
Discussion: Findings may reveal opportunities for unique structures, interventions or tools that enable ICC that could
be developed, implemented, and evaluated through future research. This information will serve as a formative needs
assessment to identify the nature of ongoing or required improvements, which can be directly used by our decision
maker collaborators, and as a framework by policy makers, cancer system managers, and DAP managers elsewhere to
strategically plan for and implement diagnostic cancer services.
Keywords: Inter-professional collaborative care, Multidisciplinary care team, Inter-professional relations,
Communication, Cooperative behavior, Diagnostic assessment program, Breast cancer, Lung cancerBackground
Need for collaborative cancer care
Most cancer patients require multimodal assessment and
treatment including radiologic and pathologic detection,
confirmation and characterization, and surgery, chemo-
therapy, and/or radiation for cure or palliation [1]. Follow-
ing initial treatment, patient needs vary as they undergo* Correspondence: Anna.gagliardi@uhnresearch.ca
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stated.follow-up surveillance to detect recurrent or secondary
cancer, with many facing physiological and psychosocial
difficulties as a result of their cancer and/or its treatment
[2]. In addition, most cancer patients require management
to prevent or treat co-morbid conditions [3]. Thus, cancer
management is complex, and compounded by the fact
that multimodal care is delivered by different profes-
sionals, in different settings, and at different time points.
Research has established that coordinated, collaborative
service delivery improves clinical (i.e., mortality, length ofal Ltd. This is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and
iginal work is properly cited. The Creative Commons Public Domain Dedication
ain/zero/1.0/) applies to the data made available in this article, unless otherwise
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health related quality of life) outcomes for a variety of
acute and chronic conditions including cancer [1,4,5]. This
concept of inter-professional collaborative care (ICC) re-
quires ongoing interaction among various types of health
professionals to assess, plan, negotiate, provide, and review
care for individual patients [6].
Barriers of collaborative cancer care
It has been proposed that one-third of cancer cases could
be prevented, another third cured, and the rest effectively
treated if management consistently complied with existing
guidelines [7]. Most cancer management guidelines rec-
ommend ICC but do not specify how this can be achieved
[8]. A non-systematic review of the literature on ICC in
cancer found that formal policies and structures improved
treatment decisions, implementation of treatment deci-
sions, documentation of treatment decisions, attendance
at joint meetings, professional diversity at meetings, com-
pleteness of information presented at meetings, manage-
ment according to guideline recommendations, time to
diagnosis or treatment, survival, role identification among
team members, team effectiveness, and staff wellbeing [9].
However, timely and appropriate ICC was challenged by
many patient, provider, team, and system level factors
[10]. Other barriers included strategic differences across
organizations, limited administrative support and identi-
fied leads for the collaborative process, and organizational
and individual provider reluctance to share resources and
power [11]. Given multiple associated benefits, efforts are
needed to promote and support ICC for the clinical man-
agement of cancer patients. First, improved understanding
of which ICC approaches lead to improved patient, pro-
vider and organizational or system outcomes is required
so that we can meaningfully evaluate whether and how
cancer patients experience ICC [12,13]. Further under-
standing of how various ICC models lead to beneficial pa-
tient, provider, institutional, and health system outcomes
will provide insight on when and in what way to imple-
ment these models.
Our research on collaborative cancer care
We have jointly conducted several research studies that
identified numerous challenges of ICC for cancer, and eval-
uated the availability and impact of interventions to support
ICC. ARG surveyed and interviewed Ontario clinicians and
managers involved in cancer care across several studies.
Participants identified numerous ICC challenges, such as
timely access to testing for diagnosis and staging, lack of
human and technical resources, identifying and commu-
nicating with specialists, coordinating referral to and back
from specialists, confusion among multidisciplinary team
members about who was to coordinate management, and
the need for system level support [14-19]. Interventionsto support ICC suggested by participants included pa-
tient held medical records, cancer specific medical record,
standardized referral and reply forms, centralized cancer
diagnostic facilities, regional outreach clinics, and use of
telemedicine. ARG conceptually analyzed the literature to
describe models of ICC [20]. Determinants of positive ob-
jective and subjective patient, team and organizational
outcomes included system or organizational support, team
structure, and team processes. ARG reviewed empirical
research evaluating ICC for cancer patients [20]. Twenty-
two studies of mixed design published between 2001 and
2009 were eligible. The majority of studies (17/22) as-
sessed the role of general practitioners and supportive/pal-
liative care workers in cancer patient follow-up. Five of 22
studies evaluated ICC for diagnosis or treatment decision
making. Apart from tumor boards, no studies described
interventions to enable ICC. Collectively this research sug-
gests that most cancer providers function through parallel
or consultative, rather than integrated models of care.
FCW spearheaded several investigations to describe and
evaluate multidisciplinary cancer conferences (MCCs) as
an intervention to support ICC. Also known as tumor
boards, these are defined as regularly scheduled meetings
where healthcare providers discuss the treatment of indi-
vidual cancer patients [1]. First, she chaired a multidiscip-
linary panel to issue an evidence- and consensus-based
guideline describing MCCs [1]. FCW conducted a system-
atic review of the literature to examine the impact of ICC
on clinical outcomes [21]. Twelve studies of various design
reported statistically significant association between ICC
and survival. General surgeons were surveyed to identify
individual and organizational barriers to MCC adoption
[22]. Surgeons said that MCCs were not well supported
institutionally or widely accessible, few had a designated
coordinator, and most reviewed only rare or select cases
rather than all new cancer patients. Interviews and obser-
vation were used to explore MCC use in four hospitals
[23]. Thirty-seven MCCs were observed at three hospitals,
and 48 clinicians and administrators were interviewed. In-
stitutions lacked the capacity to fully implement MCCs as
part of routine practice.
MJD developed a measure of cancer services integra-
tion and conducted a population-based survey of Ontario
health professionals to evaluate integration. The study
identified 12 factors that accounted for the majority of
variation in cancer services integration [24]. This work
emphasized how leadership, coordination, resource alloca-
tion, and communication influence overall integration of
cancer services. Further analysis of this data revealed vari-
ability in access to electronic health records (EHRs) across
different provider groups, organization types, and geo-
graphic locations, which may limit ICC [25]. Another ana-
lysis focused specifically on the benefits of MCCs as a
model of ICC [26]. Overall, 74% of respondents were
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regular participants.
Diagnostic assessment programs
MCCs represent one model of ICC for treatment decision
making. The time interval from suspicion to diagnosis of
cancer involves numerous consultations and testing, and is
a confusing time for patients. Timely diagnosis can lead to
improved access to MCCs or other consultation, earlier
treatment and a better prognosis [1-21]. Clinicians and
managers suggested the need to improve ICC earlier in the
cancer trajectory given barriers of access to, and coordin-
ation of diagnosis and staging, and recommended central-
ized diagnostic facilities [14-19]. An expert panel assembled
by the provincial cancer agency issued organizational stan-
dards for Diagnostic Assessment Programs (DAPs) to co-
ordinate diagnostic tests and integrate multidisciplinary
expertise [27,28]. A summary of recommended DAP fea-
tures appears in Table 1.
Study rationale
ICC for cancer leads to multiple system, organizational,
professional, and patient benefits. However, our analysis
of conceptual literature did not reveal optimal ways to
achieve ICC, and our review of empirical literature re-
vealed that no interventions apart from MCCs have been
used to promote ICC for cancer care. Our research with
health professionals identified limited support for, use of,
and access to interventions that enable ICC for cancer, par-
ticularly outside of designated cancer hospitals in commu-
nity settings where the majority of cancer care takes place,
and for cancer diagnosis. DAPs appear to be a promising
model by which to enable ICC. In 2007, the provincial can-
cer agency funded four pilot DAPs and all achieved reduc-
tions in wait times (www.cancercare.on.ca/pcs/diagnosis/
diagprograms/). Hospital one reduced median time from
suspicion of breast cancer to biopsy by 60% (38 to 15 days)
and from suspicion to diagnosis by 53% (42 to 20 days);
hospital two reduced time from referral to colonoscopy for
patients with positive fecal occult blood test results by 78%;
hospital three reduced lung cancer wait times from 113 to
69 days for referral to diagnosis; and hospital four reduced
lung cancer wait times from 120 to 44 days for suspicion
to diagnosis.
Wait times are only one possible outcome of ICC. We
require more information about how to design and im-
plement DAPs to optimize ICC and achieve the range of
associated beneficial outcomes. We conducted a system-
atic review of the cancer literature to describe clinical
and economic evaluations of DAPs [29]. Most of the 20
eligible studies did not base their evaluations on guide-
line recommendations or quality indicators, or include
economic evaluations. Several DAPs were implemented
across Ontario, so more comprehensive evaluation waswarranted and possible to better understand how various
DAP models enabled ICC. The purpose of this study is to:
1. Describe DAP structure, function and outcomes
according to published DAP standards, clinical
guideline recommendations, and a theoretical
framework of ICC.
2. Conduct a pilot costing analysis of delivering
diagnostic services with DAPs.
3. Explore challenges of DAP implementation and
operation, and associated ICC.
4. Issue recommendations that may optimize the
implementation, operation and outcomes of DAPs.
This research will not evaluate DAPs from the perspec-
tive of patients. While crucial, that objective warrants separ-
ate multi-year investigation to explore patient preferences
for diagnostic care first through review of the literature,
then by interviewing patients with various characteristics
who did and did not experience DAP care. This would es-
tablish patient-informed performance measures of diagnos-
tic services and ICC, which do not exist. We found that
patient views about cancer care performance measures dif-
fered from those of health professionals, thus development
of patient-informed performance measures is necessary to
fully evaluate the services provided by DAPs and the degree
to which the DAP model enables ICC [30]. Instead, this
proposal responds to the expressed needs of our research
partners, and for multiple reasons including feasibility, fo-
cuses first on evaluating DAPs according to evidence-based
standards for DAPs and clinical care delivery, and by
soliciting the views of involved health professionals. This
preliminary evaluation is needed to establish a baseline
understanding of how DAPs were implemented and func-
tion. Only then will we have sufficient insight on factors
influencing DAP outcomes that we could ask patients
about, and an established relationship with DAP collabo-
rators to enable an expanded research study that would
include patient recruitment.
Methods
Design
A case study approach was chosen to explore multiple
factors that influence ICC including DAP structure, pro-
cesses and outcomes [31]. These will be assessed accord-
ing to DAP standards and guideline recommendations
for staging and diagnosis of breast [32-34] and lung can-
cer [27,28]. This will enable comparison between ‘cases’
(DAPs) that vary by type of cancer, academic status, and
geographic region. This may identify whether and how
differences in DAP leadership, staffing, resources, and refer-
ral patterns influence ICC, or whether ICC must be enabled
differently by condition. This approach is suitable for exam-
ining complex issues that require holistic interpretation
Table 1 DAP standards
Component Description
Team composition Administrative
• Director/manager
• Reception, clerical and bookings
Health professionals
• Assessment coordinators (examples):
• Radiologists
• Pathologists
• Primary care
• Psychosocial support
Specialists
• Surgeon specialists
• Respirologists (lung)
• Endoscopists (colorectal and other)
Technicians
• Ultrasound technologists
• Mammographers (breast)
Scope of diagnostic activity Examination
(diagnostic activity differs
depending on disease site)
• Physical exam
• Other disease site specific
Imaging, diagnostic and
staging procedures
• Ultrasound
• MRI
• X-ray
• CT scan
• PET
• Upper endoscopy
• Colonoscopy
• Bronchoscopy
• Cystoscopy
• Bone scan
• Mammography
• Other disease site specific
Surgical consultation and procedures
• Biopsy
• Fine needle aspiration cytology
• Biopsy
Pathology and laboratory medicine
• Standardized surgical pathology
requisition forms
• Routine analysis and
pathology reporting
• Special pathological studies such
as markers, flow, molecular, etc
• Clinical lab testing of tumour
markers, hematology, etc.
Table 1 DAP standards (Continued)
Supportive care
• Education/psychosocial support
• Dietetics
• Genetic counselling
• Other supportive services
• Access • Regionalized, centralized
• One stop
• Virtual
• Entry point • Primary care providers or specialist
• Screening program
• Self referral
• Operational features • Entry
• Fast access booking
• Priority booking
• Open-access booking
• DAP core elements • Assessment coordinator
• Multidisciplinary care conference
(MCC) team/treatment team
• Cross-DAP collaboration
• Provincial indicators of
quality for cancer DAPs
• Time intervals
• Clinical outcomes
• Quality of care
• Patient satisfaction
• Guidelines, standards and
services frameworks
• Guidelines and service frameworks
for primary care providers
• Evidence-based investigative
algorithms and guidance documents
• Wait-times benchmarks
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different sources. Data will be collected from medical re-
cords and interviews. Four hospitals from different regions
of Ontario agreed to participate. Two are considered aca-
demic teaching hospitals. Each site features a breast DAP
and a lung DAP, for a total of eight participating DAPs.
This study was reviewed and approved by the University
Health Network Research Ethics Board, and research ethics
boards at each of the four participating hospitals.Conceptual framework
The overall goal of this study is to explore how DAPs
enable ICC and associated outcomes. ICC was defined as
‘interaction among various types of health professionals to
plan or evaluate services, or plan, provide or review results
or outcomes for individual patients’. There is no single
existing model or theory that describes factors influencing
the quality of ICC, so we compiled a conceptual frame-
work from several sources. We had reviewed several bodies
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interaction for patient management according to the
concepts of teamwork, inter-professional collaboration,
continuity of care, integrated service delivery, inter-
organizational collaboration and case management, and
extracted data on common domains and elements, and as-
sociated outcomes [20]. This generated core components
and enablers of ICC that were common across the models.
Organizational standards for DAPs that are described in
Table 1 [27,28] were mapped onto this preliminary frame-
work. The conceptual framework was expanded by adding
challenges [10-26] and beneficial outcomes [9-21] identi-
fied in our background review of the literature. We also
reviewed clinical guidelines for breast [32-34] and lung
cancer [27,28] to incorporate elements of desirable care
delivery and outcomes. The resulting conceptual frame-
work (Figure 1) will be used to inform the development of
data collection instruments and data analysis. Findings
will be used to validate and extend the conceptual frame-
work to describe how DAP structure, function and sup-
port enable ICC, and associated outcomes.Medical record review to describe DAP services
and outcomes
Approach
To describe DAP function and outcomes, and gather in-
formation that will enable costing, recommendations
expressed in DAP standards and clinical guidelines will
be assessed through retrospective observational study. Data
will be acquired from databases maintained by participat-
ing DAPs and the provincial cancer agency, and confirmed
by and supplemented with review of medical records.Figure 1 Conceptual framework describing factors that influence howSampling
Eligible patients include those 18 years of age or older
with suspected lung or breast cancer who were referred
to participating DAPs between 1 January 2012 and 31
December 2012. Based on input from collaborating sites,
we initially estimated that this includes a mean of 15 new
patients per month by two types of cancer in four sites for
an annual total of 360 patients per site, and an overall
total of 1,440 patients. Assuming a type I error (alpha) rate
of 0.05, power of 0.80, and equal sample sizes for two
comparative groups (i.e., academic/community status or
breast/lung cancer), 170 patients (85 in each group) in
total would be required to detect a statistically significant
difference in compliance with a given DAP or clinical
guideline standard of 15%. Thus, estimated patient sam-
pling is more than sufficient to identify variations in
process or outcome performance measures according to
varying DAP features. However, DAPs vary in case vol-
ume. To give equal weight to each DAP at each participat-
ing site based on patient volume, 15% of patients will be
randomly sampled from among those newly referred dur-
ing the given time period. For all sites, this is equal to or
greater than minimal sample sizes estimated by traditional
power calculation.
Data collection and analysis
Data reflecting DAP and guideline recommendations for
diagnostic activity (Table 1) will be extracted from med-
ical records. A trained data abstractor will visit partici-
pating sites. Before this, a data extraction form will be
developed and independently pilot tested on five cases
by two individuals. They will compare congruence of ex-
tracted data to assess how the form should be revised.DAPs achieve ICC and associated benefits.
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data extraction form is satisfactory and congruence of
independently extracted data is high. During chart re-
view, 5% of charts will be re-abstracted for data quality
monitoring. Summary statistics will be used to report
compliance with DAP and guideline standards for pa-
tients overall and by DAP, academic status, and type of
cancer. Statistical significance of differing outcomes will
be reported with the Pearson’s chi-square test. A general-
ized linear mixed model approach will be used to address
binary and continuous process and outcome variables.
Hierarchical modeling (patient level one, hospital level two)
will be used to allow for clustering by hospital.
Pilot costing analysis of DAP diagnostic visits and services
Approach
Our ultimate goal is to conduct a cost-effectiveness ana-
lysis (CEA), but this is a complex undertaking requiring
considerable data on the actual number and nature of
services provided per patient and their cost. The purpose
of CEA is not hypothesis testing, but rather it is estima-
tion [35]. To do a CEA, one needs to compute estimates
of the extra cost (ΔC) and the extra effect (ΔE) of an
intervention. The ratio of ΔC to ΔE is called the incre-
mental cost-effectiveness ratio (ICER) and is the main
statistic in CEA. Such data are not readily available in
administrative databases and often requires primary data
collection from medical records. We currently do not
know whether data required for a CEA of DAPs is available
in medical records. Therefore, we will conduct a pilot study
to explore the feasibility of estimating the ICER using
person-level data from medical records and other sources.
This will allow us to prepare for a future more comprehen-
sive CEA of DAPs across multiple sites.
Sampling
Because this is a pilot study, we will focus our efforts on
one breast and one lung DAP at one site to examine
whether and how data routinely collected in medical re-
cords can be used as the main source of data for costing.
This site was chosen because they have collected DAP-
specific data for several years and used it for internal
reporting, and the site is easily accessible to investigators,
which facilitates data collection and minimizes study costs.
The patient sample will be similar to that used for the
retrospective observational study at this site.
Data collection and analysis
As the purpose of this pilot costing analysis is to explore
the potential for estimating costs using readily available
program, hospital, and patient data, we will focus on data
related to service use. Costs are calculated as ‘price’ times
‘quantity’ , and the data we are collecting from patient
charts are the ‘quantities’. The number and nature of alldiagnostic services provided to each eligible patient will be
extracted. This will be reviewed with collaborators to cre-
ate a standardized list of defined, unique services, for
which costs will be acquired from hospital sources and
OHIP billing codes. The question of interest is whether the
patient chart provides relevant data on health service use.
By ‘costing’ the data in the charts, this produces a fuller es-
timate of Total Cost. We will use a paired t-test for each
patient to test whether the Total Cost using the chart data
is statistically significantly different from the Total Cost
using data acquired from hospital or program sources.
Key informant interviews
Approach
Telephone interviews will be conducted with health pro-
fessionals, staff, and referring physicians from each DAP
to learn about barriers and facilitators of ICC. Qualita-
tive methods based on a grounded approach will be used
to guide sampling, data collection, and analysis [36]. The
theoretical framework will inform interview questions
and their analysis.
Sampling and recruitment
Interviewees will be identified by the collaborating key
contact for each DAP (known sponsor approach). One
manager, nurse, and physician from each DAP, plus two
referring physicians will be recruited, for a minimum
target of 40 interviews, to collect information from indi-
viduals who vary by health profession and site sampling
criteria (purposive sampling). They will be invited by regu-
lar mail and email, and asked to sign and return a signed
consent form. Information from representative, rather than
a large number of participants is needed in qualitative re-
search. It is not meant to produce generalizable results, but
to provide an in-depth exploration of issues. Sampling is
concurrent with data collection and analysis, and proceeds
until no further unique themes emerge (thematic satur-
ation). If saturation is not achieved after 40 interviews, fur-
ther interviews will be pursued with additional individuals
identified by the key contact, and by interviewees (snowball
sampling).
Data collection and analysis
A semi-structured interview guide will be developed to
explore how DAP structure, operation, and other factors
influence or challenge ICC. Participants will be prompted
to discuss system or organizational support, team struc-
ture, and team processes, and how these factors influence
ICC and outcomes. The interview guide will be pilot-
tested with one manager and one clinician from a DAP
not participating in the study to refine the wording and
flow of questions. Telephone interviews of approximately
30 minutes will be audio-recorded, and converted to text
by a professional transcriptionist. Unique themes will be
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tive technique [37,38]. Transcripts will be read independ-
ently by two individuals to identify, define, and organize
themes. A log will be maintained of emerging codes, their
definition, and sample narrative illustrating application of
that code (open coding). The narrative will be reviewed
(constant comparative technique) to identify all instances
of the coding framework, and items not matching the
framework, to determine how to expand or merge the-
matic codes (axial coding). The two will compare findings
and achieve consensus through discussion. A third individ-
ual will resolve any conflicts. Coded text will be tabulated
by theme and DAP to compare and interpret results.
Discussion
As our population ages, an increase in the absolute number
of cancer patients is expected. To improve their care and
outcomes enhanced ICC is needed. The proposed study
constitutes phase one of a longitudinal research program
that will evaluate existing and alternative interventions to
support ICC for cancer. It also represents the next phase in
the evaluation of DAPs as a model by which to enable ICC
following evaluation of diagnostic wait times for pilot pro-
gram implemented across Ontario.
The proposed study may be limited in a number of ways.
Medical record review will not be comprehensive of all
cases at all DAPs across Ontario, and clinical measures are
limited to wait times and receipt of basic diagnostic tests.
However, the study is exploratory overall, and will attempt
to identify whether particular DAP features that enable
ICC appear to be associated with shorter wait times or
more consistent receipt of diagnostic tests. If there are
trends, this would warrant a future, larger-scale study to
confirm such associations. Site sampling enhances the
relevance of findings because we will include DAPs with a
variety of features. Evaluation is informed by published
and evidence-based DAP and clinical guidelines, and by a
theoretical framework of ICC generated by review of sev-
eral relevant bodies of knowledge. The costing component
will establish a taxonomy of DAP visits and services, and
associated costs that could be used by all DAPs to calcu-
late costs, and in a future cost effectiveness study. The lim-
itations of available data for cost effectiveness analysis are
currently unknown, so we are taking a practical approach
in conducting an exploratory/pilot costing analysis as the
first step. Recruitment for qualitative interviews is always
challenging, but we have identified a lead key informant at
each site who will identify and link us with various health
professionals and staff to achieve interviews. Interviews
will be conducted with health professionals in various pro-
fessional roles both internal and external to collaborating
DAPs to enhance the depth and relevance of findings. Case
study design triangulates data from multiple sources col-
lected in multiple ways to generate in-depth information,which will be further integrated and interpreted through
ongoing interaction with collaborators. A variety of add-
itional factors enhance the feasibility and successful con-
duct of the proposed research. The research team, which
has successfully collaborated on numerous previous stud-
ies, includes individuals with training, expertise, and ex-
perience in case studies, economic analyses, and qualitative
methods (interviews, case studies), and experience in
evaluating models of ICC. We were approached by
project-specific partners to address their expressed in-
formation needs. This means they are interested in help-
ing us to conduct the research, and will use the findings.
Multiple products and outcomes are expected. By in-
teracting with various types of decision makers, we will
identify barriers of ICC and associated suggestions for
improvement. This may reveal opportunities for unique
structures, interventions, or tools that enable ICC apart
from MCCs or DAPs that could be developed, imple-
mented, and evaluated through future collaborations be-
tween researchers and decision-makers. This study will
describe DAP evolution and the extent of DAP implemen-
tation in Ontario according to compliance with standards,
and feedback of stakeholders both internal and external to
participating DAPs. This information will serve as a forma-
tive needs assessment to identify the nature of ongoing/re-
quired improvements, which can be directly used by our
decision-maker collaborators, and as a framework by pol-
icy makers, cancer system managers, and DAP managers
elsewhere to strategically plan for future services. Study
findings will be shared with stakeholders representing dif-
ference professional roles and organizations from across
Ontario to issue recommendations for DAP structure,
implementation, and operation. Mechanisms by which
to achieve ICC could then be better described in can-
cer guidelines and other tools that specify ICC. Cost-
effectiveness analysis can establish a mechanism for
evaluating the benefit of ICC as delivered by DAPs. Such
modeling can be used by policy makers, cancer system
managers, and DAP managers elsewhere. Our pilot costing
exercise will be used to plan future cost-effectiveness stud-
ies. The study findings can be used to develop a theoretical
framework of ICC, since our review of conceptual litera-
ture revealed the need for further development of mea-
sures by which to evaluate ICC. We and others can use
this in future research. By identifying gaps in knowledge,
we establish the need for additional primary investigation
that describes current patterns of ICC and associated out-
comes. By engaging with multiple stakeholders we develop
relevant, feasible, and desirable interventions for enhan-
cing DAP care, and more effectively exchange ideas and
transfer the findings of this research to policy and practice.Competing interests
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